Policy support important as India largely an out-of-pocket market: Panchal

AstraZeneca Pharma India Managing Director and Country President, Sanjeev Panchal, talks to Shine Jacob about the company's future plans in an interview

British drug major AstraZeneca is working on several clinical trials and several cancer-related projects in India. The company is trying to bring in technology to speed up the introduction of its global products.

AstraZeneca Pharma India Managing Director and Country President Sanjeev Panchal talks to Shine Jacob about the company’s future plans in a face-to-face interview. Edited excerpts.

With your global plans to reach $80 billion in revenue by 2030, what will be the Indian market’s contribution to that?

We achieved around $45 billion in sales last year globally, and almost $10 billion was invested in research and development.

Our mission